LOXL2 and neoplasm: A recent study showed that corilagin attenuates bleomycin-induced fibrogenesis and tumor metastasis by inhibiting tumor growth factor β1-induced epithelial-mesenchymal transition in the presence of active lysyl oxidase-like 2 [49].